Clinical trial
Clinical Evaluation of the OtoSight
NCT03890107 · PhotoniCare, Inc., Industry · Completed
Key facts
| NCT number | NCT03890107 |
|---|---|
| Title | Clinical Evaluation of the OtoSight |
| Official title | Clinical Evaluation of a New Middle Ear Diagnostic to Support FDA Regulatory Clearance |
| Lead sponsor | PhotoniCare, Inc., Industry |
| Collaborators | Carle Foundation Hospital Children's National Research Institute National Institute on Deafness and Other Communication Disorders (NIDCD) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Otitis Media |
| Intervention type | Device |
| Interventions | OtoSight Middle Ear Scope |
| Enrollment | 110 |
| Start date | Apr 15, 2019 |
| Primary completion | Apr 30, 2021 |
| Completion | Apr 30, 2022 |
| First posted | Mar 26, 2019 |
| Last update posted | May 22, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: